Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITATOPS
NCT00097669Phase 3Completed
- Sponsor
- VITATOPS
- Start
- Nov 1998
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 20
01
Overview
A Phase 3 trial of folic acid, pyridoxine, vitamin b12 in stroke, Transient Ischemic Attack (TIA), sponsored by VITATOPS. Started Nov 1998; status: completed.
02
Drugs
folic acidpyridoxinevitamin b12
03
Conditions
strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT00097669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097669.